| Serial Number | 97041301 |
| Word Mark | APTAH |
| Filing Date | Thursday, September 23, 2021 |
| Status | 732 - THIRD EXTENSION - GRANTED |
| Status Date | Monday, July 8, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, November 29, 2022 |
| Goods and Services | Pharmaceutical preparations for the configuration, modulation and correction of RNA transcript splicing, capping and tailing for the treatment of genetic diseases; pharmaceutical preparations for the configuration, modulation and correction of RNA for the treatment of genetic diseases; pharmaceutical preparations for restoring and reprograming RNA-protein interactions for the treatment of genetic diseases; pharmaceutical preparations for the treatment of genetic diseases associated with gene dysregulation, inhibition or suppression of gene expression; pharmaceutical preparations for the treatment of genetic diseases; gene therapy products, namely, molecules in the nature of genetically engineered tissues for controlling gene expression; medical molecular diagnostic tests for testing bodily fluid for the detection of genetic diseases; medical diagnostic tests for the detection of neurodegenerative, oncological and infectious diseases |
| Goods and Services | Biomolecules in the nature of gene therapy products, namely, genetically engineered stem cells in the nature of synthetic cDNAs for controlling gene expression for medical and scientific research |
| Goods and Services | Research and development of pharmaceuticals, namely, therapies for the configuration, modulation and correction of RNA transcript splicing, capping and tailing; scientific research and development of therapies in the fields of biotechnology, genetic medicine, gene therapy, DNA, RNA, molecules and proteins; pharmaceutical products design and development in the field of biomolecules for medical and scientific use, and medical treatment; pharmaceutical drug design and development featuring biomolecules |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, October 25, 2021 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, October 25, 2021 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, October 25, 2021 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Aptah Bio Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | San Carlos, CA 94070 |
| Party Name | Aptah Bio Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | San Carlos, CA 94070 |
| Event Date | Event Description |
| Wednesday, June 29, 2022 | NON-FINAL ACTION E-MAILED |
| Monday, September 27, 2021 | NEW APPLICATION ENTERED |
| Monday, October 25, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, June 24, 2022 | ASSIGNED TO EXAMINER |
| Wednesday, June 29, 2022 | NON-FINAL ACTION WRITTEN |
| Wednesday, June 29, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, August 23, 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, August 23, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, August 24, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, October 6, 2022 | FINAL REFUSAL WRITTEN |
| Thursday, October 6, 2022 | FINAL REFUSAL E-MAILED |
| Thursday, October 6, 2022 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Friday, October 7, 2022 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| Friday, October 7, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, October 7, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, October 25, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, November 9, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, November 29, 2022 | PUBLISHED FOR OPPOSITION |
| Tuesday, November 29, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, January 24, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Thursday, June 22, 2023 | SOU TEAS EXTENSION RECEIVED |
| Thursday, June 22, 2023 | SOU EXTENSION 1 FILED |
| Thursday, June 22, 2023 | SOU EXTENSION 1 GRANTED |
| Saturday, June 24, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, July 8, 2024 | SOU TEAS EXTENSION RECEIVED |
| Monday, July 8, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, July 8, 2024 | SOU EXTENSION 3 FILED |
| Monday, July 8, 2024 | SOU EXTENSION 3 GRANTED |
| Friday, January 26, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, January 24, 2024 | SOU TEAS EXTENSION RECEIVED |
| Wednesday, January 24, 2024 | SOU EXTENSION 2 FILED |
| Wednesday, January 24, 2024 | SOU EXTENSION 2 GRANTED |